Acrobiosystems Co.,Ltd. (SHE:301080)
China flag China · Delayed Price · Currency is CNY
76.02
-7.60 (-9.09%)
Nov 16, 2026, 4:00 PM EST

Acrobiosystems Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Net Income
194.73165.57123.83153.59203.73174.21
Depreciation & Amortization
65.8565.8553.2542.0234.513.94
Other Amortization
22.2822.2819.0217.459.63.99
Loss (Gain) From Sale of Assets
-0.07-0.070.35--0.21-0.28
Asset Writedown & Restructuring Costs
4.114.11037.7624.225.7
Loss (Gain) From Sale of Investments
-10.57-10.571.48-5.37-21.63-8.1
Provision & Write-off of Bad Debts
-0.03-0.030.031.711.03-
Other Operating Activities
-11.0537.0336.09-9.34-4.430.4
Change in Accounts Receivable
74.1574.15-41.23-56.05-17.64-26.27
Change in Inventory
-131.03-131.03-83.21-81.32-52.91-34.44
Change in Accounts Payable
135.69135.69-6.1429.8137.2217.4
Change in Other Net Operating Assets
11.611.6-6.37-5.937.251.18
Operating Cash Flow
336.82355.7484.71111.2202.19138.01
Operating Cash Flow Growth
94.69%319.97%-23.82%-45.00%46.51%43.02%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Capital Expenditures
-235.82-205.08-167.26-128.69-284.29-61.7
Sale of Property, Plant & Equipment
-5.141.214.7100.35-
Cash Acquisitions
---1.731.92--
Investment in Securities
-50.2-220.98276.980.19-913.61-722.05
Other Investing Activities
81.21104.710.125.2621.118.05
Investing Cash Flow
-209.95-320.14112.85-91.32-1,176-775.7

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Short-Term Debt Issued
---6--
Long-Term Debt Issued
-55.2897.46---
Total Debt Issued
62.6455.2897.466--
Long-Term Debt Repaid
--110.85-42.78-31.93-17.61-9.54
Lease Payments
-23.39-23.39-26.78-31.93-17.61-9.54
Net Debt Issued (Repaid)
38.1-55.5754.68-25.93-17.61-9.54
Issuance of Common Stock
8.68-7.06-13.52,118
Repurchase of Common Stock
-23.85-23.85-12-10--
Common Dividends Paid
-101.86-85.55-108.21-120-120-
Other Financing Activities
6.36-14.44----18.21
Financing Cash Flow
-72.57-179.42-58.48-155.93-124.112,090

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Foreign Exchange Rate Adjustments
-15.62-7.767.6513.856.42-2.26
Net Cash Flow
38.68-151.59146.73-122.2-1,0921,450

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Free Cash Flow
101150.66-82.56-17.49-82.176.31
Free Cash Flow Growth
535.75%-----6.39%
Free Cash Flow Margin
9.85%17.98%-12.80%-3.22%-17.30%19.82%
Free Cash Flow Per Share
0.600.90-0.49-0.10-0.490.57
Levered Free Cash Flow
-100.55-118.22-156.74-25.36-173.0141.41
Unlevered Free Cash Flow
-100.41-116.54-154.52-23.67-171.1742.13
Free Cash Flow After Leases
77.6127.26-109.34-49.42-99.766.76

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash Income Tax Paid
150.3453.9760.5548.6736.4341.4
Change in Working Capital
71.5571.55-149.35-126.63-44.62-51.85